ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1 (Updated August 4, 2021)

MLA

“ACVR1 Antibodies Exacerbate Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva (FOP) by Activating FOP-Mutant ACVR1 (Updated August 4, 2021).” Obesity, Fitness & Wellness Week, Aug. 2021, p. 1347. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.672112540&authtype=sso&custid=ns315887.

APA

ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1 (Updated August 4, 2021). (2021, August 21). Obesity, Fitness & Wellness Week, 1347.

Chicago

Obesity, Fitness & Wellness Week. 2021. “ACVR1 Antibodies Exacerbate Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva (FOP) by Activating FOP-Mutant ACVR1 (Updated August 4, 2021),” August 21. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.672112540&authtype=sso&custid=ns315887.